The Food and Drug Administration (FDA) has reached an agreement with Abbott Nutrition on a plan to restart production at the Michigan baby formula plant to combat the shortage crisis.
This past February, Abbott Nutrition instituted a recall after four illnesses were reported in babies who had consumed powdered formula from the Sturgis, Michigan plant, helping to fuel the ongoing baby formula shortage that has created considerable concern among parents.
“After a six-week inspection, FDA investigators published a list of problems in March, including lax safety and sanitary standards and a history of bacterial contamination in several parts of the plant,” noted the Associated Press.
“Chicago-based Abbott has emphasized that its products have not been directly linked to the bacterial infections in children,” it added. “Samples of the bacteria found at its plant did not…
